| |
|
|
|
|
|
|
|||
|
Blood, 16 July 2009, Vol. 114, No. 3, pp. 723-732. Prepublished online as a Blood First Edition Paper on April 15, 2009; DOI 10.1182/blood-2009-02-205930.
VASCULAR BIOLOGY Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures1 King's British Heart Foundation Centre, King's College London, London, United Kingdom; 2 Paris-Cardiovascular Research Center, Inserm U970, Hôpital Européen Georges Pompidou, Université Paris-Descartes, Paris, France; 3 King's College Hospital, National Health Service (NHS) Foundation Trust, Blood Sciences Laboratory Services, London, United Kingdom; 4 Department of Haematological Medicine, King's College London, London, United Kingdom; 5 Molecular Cardiology, Department of Medicine III, University of Frankfurt, Frankfurt, Germany; 6 Department of Neurology, Medical University Innsbruck, Innsbruck, Austria; 7 Center for Anatomy and Cell Biology, Medical University Vienna, Vienna, Austria; and 8 Department of Vascular Biology and Thrombosis Research, Centre for Bio-Molecular Medicine and Pharmacology, Medical University of Vienna, Vienna, Austria The concept of endothelial progenitor cells (EPCs) has attracted considerable interest in cardiovascular research, but despite a decade of research there are still no specific markers for EPCs and results from clinical trials remain controversial. Using liquid chromatography–tandem mass spectrometry, we analyzed the protein composition of microparticles (MPs) originating from the cell surface of EPC cultures. Our data revealed that the conventional methods for isolating mononuclear cells lead to a contamination with platelet proteins. Notably, platelets readily disintegrate into platelet MPs. These platelet MPs are taken up by the mononuclear cell population, which acquires "endothelial" characteristics (CD31, von Willebrand factor [VWF], lectin-binding), and angiogenic properties. In a large population-based study (n = 526), platelets emerged as a positive predictor for the number of colony-forming units and early outgrowth EPCs. Our study provides the first evidence that the cell type consistent with current definitions of an EPC phenotype may arise from an uptake of platelet MPs by mononuclear cells resulting in a gross misinterpretation of their cellular progeny. These findings demonstrate the advantage of using an unbiased proteomic approach to assess cellular phenotypes and advise caution in attributing the benefits in clinical trials using unselected bone marrow mononuclear cells (BMCs) to stem cell-mediated repair.
Related Article in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||